These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15213167)

  • 21. Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
    Engel LS; Hobden JA; Moreau JM; Callegan MC; Hill JM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.
    Le Berre R; Nguyen S; Nowak E; Kipnis E; Pierre M; Quenee L; Ader F; Lancel S; Courcol R; Guery BP; Faure K;
    Crit Care Med; 2011 Sep; 39(9):2113-20. PubMed ID: 21572326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
    Lee VT; Smith RS; Tümmler B; Lory S
    Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
    Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J
    Clin Microbiol Infect; 2008 Apr; 14(4):330-6. PubMed ID: 18190571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
    Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Streptococcus pneumoniae galU gene mutation has a direct effect on biofilm growth, adherence and phagocytosis in vitro and pathogenicity in vivo.
    Cools F; Torfs E; Vanhoutte B; de Macedo MB; Bonofiglio L; Mollerach M; Maes L; Caljon G; Delputte P; Cappoen D; Cos P
    Pathog Dis; 2018 Oct; 76(7):. PubMed ID: 30215741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa.
    Filopon D; Mérieau A; Bernot G; Comet JP; Leberre R; Guery B; Polack B; Guespin-Michel J
    BMC Bioinformatics; 2006 May; 7():272. PubMed ID: 16734902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of Proteus mirabilis: defectiveness in polymyxin B resistance, swarming, and virulence.
    Jiang SS; Lin TY; Wang WB; Liu MC; Hsueh PR; Liaw SJ
    Antimicrob Agents Chemother; 2010 May; 54(5):2000-9. PubMed ID: 20160049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo.
    Vance RE; Rietsch A; Mekalanos JJ
    Infect Immun; 2005 Mar; 73(3):1706-13. PubMed ID: 15731071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis.
    von Götz F; Häussler S; Jordan D; Saravanamuthu SS; Wehmhöner D; Strüssmann A; Lauber J; Attree I; Buer J; Tümmler B; Steinmetz I
    J Bacteriol; 2004 Jun; 186(12):3837-47. PubMed ID: 15175297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins.
    Faure K; Sawa T; Ajayi T; Fujimoto J; Moriyama K; Shime N; Wiener-Kronish JP
    Respir Res; 2004 Feb; 5(1):1. PubMed ID: 15040820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections.
    Preston MJ; Seed PC; Toder DS; Iglewski BH; Ohman DE; Gustin JK; Goldberg JB; Pier GB
    Infect Immun; 1997 Aug; 65(8):3086-90. PubMed ID: 9234758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of galU mutation on Pseudomonas syringae-plant interactions.
    Deng WL; Lin YC; Lin RH; Wei CF; Huang YC; Peng HL; Huang HC
    Mol Plant Microbe Interact; 2010 Sep; 23(9):1184-96. PubMed ID: 20687808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel sensor kinase-response regulator hybrid regulates type III secretion and is required for virulence in Pseudomonas aeruginosa.
    Laskowski MA; Osborn E; Kazmierczak BI
    Mol Microbiol; 2004 Nov; 54(4):1090-103. PubMed ID: 15522089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
    Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
    Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyphosphate kinase 1 and the ocular virulence of Pseudomonas aeruginosa.
    Parks QM; Hobden JA
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):248-51. PubMed ID: 15623780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system.
    Ader F; Le Berre R; Faure K; Gosset P; Epaulard O; Toussaint B; Polack B; Nowak E; Viget NB; Kipnis E; Guery BP
    Infect Immun; 2005 Jul; 73(7):4263-71. PubMed ID: 15972518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection.
    Kernacki KA; Hobden JA; Hazlett LD; Fridman R; Berk RS
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1371-8. PubMed ID: 7775115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UTP: alpha-D-glucose-1-phosphate uridylyltransferase of Escherichia coli: isolation and DNA sequence of the galU gene and purification of the enzyme.
    Weissborn AC; Liu Q; Rumley MK; Kennedy EP
    J Bacteriol; 1994 May; 176(9):2611-8. PubMed ID: 8169209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.